businesspress24.com - MIMEDX ENVIRONMENTAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti,
 

MIMEDX ENVIRONMENTAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MiMedx Group, Inc. - MDXG

ID: 1261787

(firmenpresse) - NEW ORLEANS, LA -- (Marketwired) -- 09/09/13 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in a securities class action lawsuit against MiMedx Group, Inc. (NASDAQ: MDXG), if they purchased the Company's securities during the period between March 15, 2013 and September 4, 2013, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased shares of MiMedx and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850, or email KSF Managing Partner Lewis Kahn () or KSF Partner Melinda Nicholson (). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by .

About the Lawsuit
MiMedx and certain of its executives are charged with issuing a series of materially false and misleading statements about whether its AmnioFix product required U.S. Food and Drug Administration ("FDA") approval to be manufactured and marketed during the Class Period, violating federal securities laws.

On September 4, 2013, MiMedx confirmed receipt of an "Untitled Letter" the FDA sent to MiMedx on August 28, which stated that MiMedx's Surgical Biologics unit violated the Public Health Service Act by unlawfully manufacturing and marketing drugs that are also a biological product without a valid biologics license.

On this news, the price of MiMedx's shares fell drastically, by over 36%.

About Kahn Swick & Foti, LLC

To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit .







Contact:

Kahn Swick & Foti, LLC
Lewis Kahn
Managing Partner

Melinda Nicholson
Partner

1-877-515-1850
206 Covington St.
Madisonville, LA 70447


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company
@Legal Discovery Expands Into Midwest Market and Adds eDiscovery Industry Veteran to Team
Bereitgestellt von Benutzer: Marketwired
Datum: 09.09.2013 - 20:00 Uhr
Sprache: Deutsch
News-ID 1261787
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW ORLEANS, LA


Phone:

Kategorie:

Legal


Anmerkungen:


Diese Pressemitteilung wurde bisher 218 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MIMEDX ENVIRONMENTAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MiMedx Group, Inc. - MDXG
"
steht unter der journalistisch-redaktionellen Verantwortung von

Kahn Swick & Foti, LLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Kahn Swick & Foti, LLC



 

Who is online

All members: 10 572
Register today: 2
Register yesterday: 0
Members online: 0
Guests online: 136


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.